Two panels of steroid receptor luciferase reporter cell lines for compound profiling

Combinatorial Chemistry and High Throughput Screening

Volumn 14, Issue 4, 2011, Pages 248-266

  Sedlák, David ^a   Paguio, Aileen ^b   Bartůňk, Petr ^a  

^a INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

^b PROMEGA CORPORATION   (United States)

Author keywords

Cell based luciferase reporter assay; Drug discovery; Gal4; HTS; Ligand binding domain; Nuclear hormone receptor; Steroid receptor; U2OS

Indexed keywords

4 HYDROXY TAMOXIFEN; ALDOSTERONE; ANDROGEN; ANDROSTANOLONE; BECLOMETASONE; BETAMETHASONE; CORTICOSTERONE; CYPROTERONE ACETATE; DANAZOL; DEXAMETHASONE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FLUTAMIDE; FULVESTRANT; GENISTEIN; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; HYDROXYPROGESTERONE CAPROATE; LUCIFERASE; MIFEPRISTONE; MINERALOCORTICOID RECEPTOR; NILUTAMIDE; PROGESTERONE RECEPTOR; RALOXIFENE; SPIRONOLACTONE; STEROID RECEPTOR; TAMOXIFEN CITRATE; TESTOSTERONE; TRIAMCINOLONE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; ARTIFACT; CELL LINE; CHIMERA; CYTOLOGY; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENCY; ENZYME ACTIVITY; ESTROGEN RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MOLECULAR INTERACTION; PRIORITY JOURNAL;

EID: 79953315985     PISSN: 13862073     EISSN: None     Source Type: Journal    
DOI: 10.2174/138620711795222446     Document Type: Article

References (30)

1. Mangelsdorf, D. J.; Thummel, C.; Beato, M.; Herrlich, P.; Schutz, G.; Umesono, K.; Blumberg, B.; Kastner, P.; Mark, M.; Chambon, P.; Evans, R. M. The nuclear receptor superfamily: the second decade. Cell, 1995, 83 (6), 835-839.
2. Clarke, M. Meta-analyses of adjuvant therapies for women with early breast cancer: the Early Breast Cancer Trialists' Collaborative Group overview. Ann. Oncol., 2006, 17 Suppl 10, 59-62.
3. Lange, C. A.; Sartorius, C. A.; Abdel-Hafiz, H.; Spillman, M. A.; Horwitz, K. B.; Jacobsen, B. M. Progesterone receptor action: translating studies in breast cancer models to clinical insights. Adv. Exp. Med. Biol., 2008, 630, 94-111.
4. Chen, Y.; Sawyers, C. L.; Scher, H. I. Targeting the androgen receptor pathway in prostate cancer. Curr. Opin. Pharmacol., 2008, 8 (4), 440-448.
5. Coghlan, M. J.; Elmore, S. W.; Kym, P. R.; Kort, M. E. The pursuit of differentiated ligands for the glucocorticoid receptor. Curr. Top Med. Chem., 2003, 3 (14), 1617-1635.
6. Fox, E. M.; Davis, R. J.; Shupnik, M. A. ERbeta in breast cancer-onlooker, passive player, or active protector? Steroids, 2008, 73 (11), 1039-1051.
7. Wada-Hiraike, O.; Imamov, O.; Hiraike, H.; Hultenby, K.; Schwend, T.; Omoto, Y.; Warner, M.; Gustafsson, J. A. Role of estrogen receptor beta in colonic epithelium. Proc. Natl. Acad. Sci. U S A, 2006, 103 (8), 2959-2964.
8. Drummond, A. E.; Fuller, P. J. The importance of ERbeta signalling in the ovary. J. Endocrinol., 2010, 205 (1), 15-23.
9. Mak, P.; Leav, I.; Pursell, B.; Bae, D.; Yang, X.; Taglienti, C. A.; Gouvin, L. M.; Sharma, V. M.; Mercurio, A. M. ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading. Cancer Cell, 2010, 17 (4), 319-332.
10. Robyr, D.; Wolffe, A. P.; Wahli, W. Nuclear hormone receptor coregulators in action: diversity for shared tasks. Mol. Endocrinol., 2000, 14 (3), 329-347. (Pubitemid 32266074)
11. Sonneveld, E.; Jansen, H. J.; Riteco, J. A.; Brouwer, A.; van der Burg, B. Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays. Toxicol. Sci., 2005, 83 (1), 136-148. (Pubitemid 40123337)
12. Wilkinson, J. M.; Hayes, S.; Thompson, D.; Whitney, P.; Bi, K. Compound profiling using a panel of steroid hormone receptor cellbased assays. J. Biomol. Screen., 2008, 13 (8), 755-765.
13. Paguio, A.; Stecha, P.; Wood, K. W.; Fan, F. Improved dualluciferase reporter assays for nuclear receptors. Curr. Chem. Genomics, 2010, (4), 43-49.
14. Escande, A.; Pillon, A.; Servant, N.; Cravedi, J. P.; Larrea, F.; Muhn, P.; Nicolas, J. C.; Cavailles, V.; Balaguer, P. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta. Biochem. Pharmacol., 2006, 71 (10), 1459-1469.
15. Paguio, A.; Almond, B.; Fan, F.; Stecha, P.; Garvin, D.; Wood, M.; Wood, K. V. pGL4 Vectors: A new generation of luciferase reporter vectors. Promega Notes, 2005, 89, 7-10.
16. Green, S.; Walter, P.; Kumar, V.; Krust, A.; Bornert, J. M.; Argos, P.; Chambon, P. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature, 1986, 320 (6058), 134-139. (Pubitemid 16105150)
17. Fagart, J.; Wurtz, J. M.; Souque, A.; Hellal-Levy, C.; Moras, D.; Rafestin-Oblin, M. E. Antagonism in the human mineralocorticoid receptor. EMBO J., 1998, 17 (12), 3317-3325. (Pubitemid 28279506)
18. Di Croce, L.; Koop, R.; Venditti, P.; Westphal, H. M.; Nightingale, K. P.; Corona, D. F.; Becker, P. B.; Beato, M. Two-step synergism between the progesterone receptor and the DNA-binding domain of nuclear factor 1 on MMTV minichromosomes. Mol. Cell, 1999, 4 (1), 45-54. (Pubitemid 29386130)
19. Grossmann, C.; Scholz, T.; Rochel, M.; Bumke-Vogt, C.; Oelkers, W.; Pfeiffer, A. F.; Diederich, S.; Bahr, V. Transactivation via the human glucocorticoid and mineralocorticoid receptor by therapeutically used steroids in CV-1 cells: a comparison of their glucocorticoid and mineralocorticoid properties. Eur. J. Endocrinol., 2004, 151 (3), 397-406. (Pubitemid 39307329)
20. Sonneveld, E.; Riteco, J. A.; Jansen, H. J.; Pieterse, B.; Brouwer, A.; Schoonen, W. G.; van der Burg, B. Comparison of in vitro and in vivo screening models for androgenic and estrogenic activities. Toxicol. Sci., 2006, 89 (1), 173-187. (Pubitemid 43013766)
21. Quinkler, M.; Meyer, B.; Bumke-Vogt, C.; Grossmann, C.; Gruber, U.; Oelkers, W.; Diederich, S.; Bahr, V. Agonistic and antagonistic properties of progesterone metabolites at the human mineralocorticoid receptor. Eur. J. Endocrinol., 2002, 146 (6), 789-799.
22. Hyder, S. M.; Chiappetta, C.; Stancel, G. M. Interaction of human estrogen receptors alpha and beta with the same naturally occurring estrogen response elements. Biochem. Pharmacol., 1999, 57 (6), 597-601. (Pubitemid 29080748)
23. Cowley, S. M.; Parker, M. G. A comparison of transcriptional activation by ER alpha and ER beta. J .Steroid Biochem. Mol. Biol., 1999, 69 (1-6), 165-175. (Pubitemid 29305534)
24. Loven, M. A.; Wood, J. R.; Nardulli, A. M. Interaction of estrogen receptors alpha and beta with estrogen response elements. Mol. Cell Endocrinol., 2001, 181 (1-2), 151-163. (Pubitemid 32703757)
25. Rundlett, S. E.; Wu, X. P.; Miesfeld, R. L. Functional characterizations of the androgen receptor confirm that the molecular basis of androgen action is transcriptional regulation. Mol. Endocrinol., 1990, 4 (5), 708-714.
26. Jenster, G.; van der Korput, H. A.; van Vroonhoven, C.; van der Kwast, T. H.; Trapman, J.; Brinkmann, A. O. Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization. Mol. Endocrinol., 1991, 5 (10), 1396-1404.
27. Simental, J. A.; Sar, M.; Lane, M. V.; French, F. S.; Wilson, E. M. Transcriptional activation and nuclear targeting signals of the human androgen receptor. J. Biol. Chem., 1991, 266 (1), 510-518. (Pubitemid 21906153)
28. Alen, P.; Claessens, F.; Verhoeven, G.; Rombauts, W.; Peeters, B. The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription. Mol. Cell. Biol., 1999, 19 (9), 6085-6097. (Pubitemid 29399314)
29. He, B.; Kemppainen, J. A.; Wilson, E. M. FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor. J. Biol. Chem., 2000, 275 (30), 22986-22994. (Pubitemid 30646187)
30. Zhang, J. H.; Chung, T. D.; Oldenburg, K. R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen., 1999, 4 (2), 67-73. (Pubitemid 29278954)